Premature ovarian insufficiency (POI) is a clinically significant cause of infertility that affects between 1 to 3% of women of childbearing age. Symptoms include absent menses, low estrogen levels, ...

Please provide your email address to receive an email when new articles are posted on . “Measuring serum follicle-stimulating hormone (FSH) in women in their late 40s may help us forecast who will ...

For women approaching menopause, a number of changes begin to occur. One of the most common is an increase in obesity, which, in turn, raises the risk for breast cancer after menopause. That much is ...

The synthesis of follicle-stimulating hormone (FSH) in pituitary gonadotrope cells is a tightly controlled process that integrates multiple endocrine and paracrine signals. Central to this regulation ...

Please provide your email address to receive an email when new articles are posted on . Women with polycystic ovary syndrome have less increase in follicle-stimulating hormone after triptorelin ...

Diminished bone density is common among menopausal women and raises their risk of osteoporosis, bone fractures and subsequent complications. Research has traditionally focused on therapies that seek ...

Follicle-stimulating hormone receptor (FSHR) N680S–genotyped women treated with either recombinant FSH or urinary FSH had higher pregnancy rates of 51% vs 40% in non-genotyped control individuals.

Levels of bad cholesterol rise during menopause, and 10% of this increase is likely due to shifts in sex hormones. Women usually undergo menopause at the age of 48 to 52 years, leading to a decline in ...